首頁 > 市場調查報告書 > 醫療設備

導管藥物遞輸設備

市場調查報告書

商品編碼

1122421

藥物洗脫氣球市場：按產品類型、最終用戶、地區、市場規模、份額、前景、機會分析，2022-2030

Drug Eluting Balloon Market, by Product Type, by End User, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

出版日期: 2022年08月17日 | 出版商:

Coherent Market Insights | 英文 168 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

藥物洗脫球囊是塗有抗增殖藥物的血管成形術球囊，當球囊充氣至標稱壓力和指定的最短充氣時間時，通常會洗脫到血管壁中。理想的是塗在藥物洗脫球囊上的活性物質是親脂性的，具有從血管壁的高吸收率。紫杉醇因其對血管壁的高藥代動力學滲透性而主要用作活性成分，並在美國市場積極用於藥物洗脫球囊，並且已在歐洲獲批使用增加。藥物塗層球囊 (DCB)，也稱為藥物洗脫球囊 (DEB)，是作為一種控制外周血管再狹窄率的方法而開發的。它還正在進行臨床試驗，以防止冠狀動脈支架內再狹窄。球囊含有一種抗增殖藥物，當球囊擴張時，該藥物會輸送到血管壁。在用球囊血管成形術治療動脈粥樣硬化病變時，這種藥物有助於防止血管段創傷引起的新內膜增生（疤痕組織的生長）。 DCB可用於治療因定期穿刺而反復損傷血管的透析患者的動靜脈通路瘺管增生。 DCB 還用於治療因支架內瘢痕組織生長而導致的支架內再狹窄，這可能導致血管閉塞。與保守治療相比，經皮冠狀動脈介入治療的血管成形術已顯示出令人滿意的結果。

市場動態

市場上主要參與者不斷推出的產品預計將推動全球藥物洗脫球囊市場的增長。例如，2019 年 10 月，健康技術公司 Koninklijke Philips N.V. 推出了兩種新的 Stellarex 藥物塗層氣球尺寸。皇家飛利浦在其 Stellarex 0.035 英寸低劑量藥物塗層球囊 (DCB) 產品組合中推出了兩款新球囊。新的 200 毫米和 150 毫米 Stellax 0.035 英寸低劑量 DCB 已獲得美國食品和藥物管理局 (FDA) 的批准，用於治療上肢股骨或膕動脈淺表動脈的腫瘤性和再狹窄病變。新球囊擴展了 Stellarex 的產品組合，為醫生提供更多的治療選擇，用於再狹窄高風險的外周動脈疾病 (PAD) 患者。

本研究的主要特點

本報告對全球藥物洗脫球囊市場進行了深入分析，提供了以 2021 年為基準年的預測期間（2022-2030 年）的市場規模和復合年增長率 (CAGR%)。我在這裡。
它揭示了不同細分市場的潛在收入機會，並為該市場概述了一個有吸引力的投資建議矩陣。
它還提供有關市場驅動因素、限制因素、機會、新產品發布和批准、市場趨勢、區域前景以及主要參與者採用的競爭策略的重要見解。
根據公司亮點、產品組合、關鍵亮點、財務業績和戰略等參數，介紹了全球藥物洗脫球囊市場主要參與者的概況。
本研究涵蓋的主要公司包括 Medtronic、Becton、Dickinson and Company (BD)、Boston Scientific Corporation、Cook Medical、B. Braun Melsungen AG、Koninklijke Philips N.V.、Opto Circuits (India) Limited、Terumo Corporation、 Surmodics, Inc. 和 Biotronik。
本報告中的見解將使營銷人員和企業高管能夠就未來的產品發布、類型升級、市場擴張和營銷策略做出明智的決策。
本研究報告面向該行業的各種利益相關者，包括投資者、供應商、產品製造商、分銷商、新進入者和財務分析師。
利益相關者可以通過用於分析全球藥物洗脫球囊市場的各種戰略矩陣來促進他們的決策。

內容

第 1 章目的和先決條件

調查目的
先決條件
縮寫說明

第二章市場展望

舉報內容
- 市場定義和範圍
執行摘要
- 按產品類型劃分的市場概況
- 市場快照：按最終用戶分類
- 市場概況：按地區劃分
連貫的機會圖 (COM)

第 3 章市場動態、監管和趨勢分析

市場動態
- 驅動程序
- 約束因素
- 市場機會
市場趨勢
影響分析
主要亮點
PEST 分析
PORTER 分析
併購
流行病學

第 4 章全球藥物洗脫氣球市場 - 冠狀病毒 (COVID-19) 大流行的影響

整體影響
政府舉措
COVID-19 對市場的影響

第 5 章全球藥物洗脫球囊市場，按產品類型，2017-2030 年

用於冠狀動脈的藥物洗脫球囊
外周藥物洗脫球囊
其他

第 6 章全球藥物洗脫氣球市場：按最終用戶分類，2017-2030 年

醫院
CATH 實驗室
門診手術中心
其他

第 7 章全球藥物洗脫球囊市場，按地區，2017-2030 年

北美
美國
加拿大
拉丁美洲
巴西
墨西哥
阿根廷
其他拉丁美洲地區
歐洲
英國
德國
意大利
法國
西班牙
俄羅斯
其他歐洲
亞太地區
中國
印度
日本
東盟
澳大利亞
韓國
其他亞太地區
中東
海合會
以色列
其他中東
非洲
北非
中非
南非

第 8 章競爭格局

熱圖分析
市場份額分析
公司簡介
- Medtronic
- Becton, Dickinson and Company
- Boston Scientific Corporation
- Cook Medical
- B. Braun Melsungen AG
- Koninklijke Philips N.V.
- Opto Circuits（India）Limited
- Terumo Corporation
- Surmodics, Inc.
- Biotronik

第九章章節

調查方法介紹
關於出版商

簡介目錄

Product Code: CMI2459

Drug eluting balloons are angioplasty balloons that are coated with an anti-proliferative drug, which is eluted in vessel walls during the inflation of balloon, usually at nominal pressure with a specific minimal inflation time. The active substance coated on the drug eluting balloon should be lipophilic in nature to have a high absorption rate through the vessel wall. Mostly paclitaxel is used as active ingredient due to its high pharmacokinetic transfer rate into the vessel wall and it is actively used in drug eluting balloons in the U.S. market and has been already approved for use in Europe. Drug-coated balloons (DCB), also referred to as drug-eluting balloons (DEB), were created as a way to reduce very high restenosis rates in peripheral vessels. They also have been investigated in clinical trials to prevent coronary artery in-stent restenosis. The balloons carry an antiproliferative drug that is delivered to the wall of arteries when the balloon is expanded. The drug helps prevent neointimal hyperplasia (scar tissue growth) caused by trauma when the vessel segment is treated for atherosclerotic lesions with balloon angioplasty. DCBs can be used to treat hyperplasia in arteriovenous (AV) access fistulae in dialysis patients, where the vessel undergoes repeated trauma from regular punctures. DCBs are also used to treat in-stent restenosis due to scar tissue proliferation inside stents, which can cause a vessel to occlude. Angioplasty using percutaneous coronary intervention techniques revealed satisfying result compared to conservative medical treatment.

Market Dynamics

Increasing product launches by key players in market are expected to drive the global drug eluting balloon market growth. For instance, in October 2019, Koninklijke Philips N.V., a health technology company, launched two new Stellarex Drug-Coated Balloon Sizes. Royal Philips introduced two new balloons to its Stellarex 0.035" low-dose drug-coated balloon (DCB) portfolio. The new 200mm and 150mm Stellarex 0.035" low-dose DCBs have received approval from the U.S. Food and Drug Administration (FDA) for the treatment of de novo and restenotic lesions in native superficial femoral or popliteal arteries, both arteries in the upper leg. The new balloons broadened physicians' treatment options for peripheral artery disease (PAD) patients with a high risk of restenosis and expand the Stellarex portfolio.

Key features of the study:

This report provides an in-depth analysis of the global drug eluting balloon market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2022-2030), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global drug eluting balloon market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Medtronic, Becton, Dickinson and Company (BD), Boston Scientific Corporation, Cook Medical, B. Braun Melsungen AG, Koninklijke Philips N.V., Opto Circuits (India) Limited, Terumo Corporation, Surmodics, Inc., and Biotronik.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global drug eluting balloon market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts1
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global drug eluting balloon market

Detailed Segmentation:

Global Drug Eluting Balloon Market, By Product Type:
- Coronary Drug Eluting Balloon
- Peripheral Drug Eluting Balloon
- Others
Global Drug Eluting Balloon Market, By End User:
- Hospitals
- CATH Laboratories
- Ambulatory Surgical Centres
- Others
Global Drug Eluting Balloon Market, By Region:
- North America
  - By Country
- U.S.
- Canada
- Latin America
  - By Country
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
  - By Country
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
  - By Country
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
  - By Country
- GCC
- Israel
- Rest of Middle East
- Africa
  - By Region
- South Africa
- Central Africa
- North Africa
Company Profiles
- Medtronic *
  - Company Highlights
  - Products Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Becton, Dickinson and Company
- Boston Scientific Corporation
- Cook Medical
- Braun Melsungen AG
- Koninklijke Philips N.V.
- Opto Circuits (India) Limited
- Terumo Corporation
- Surmodics, Inc.
- Biotronik

"*" marked represents similar segmentation in other categories in the respective section.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Product Type
- Market Snapshot, By End User
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Market Trends
Impact Analysis
Key Highlights
PEST Analysis
PORTER's Analysis
Mergers and Acquisitions
Epidemiology

4. Global Drug Eluting Balloon Market- Impact of Coronavirus (Covid-19) Pandemic

Overall Impact
Government Initiatives
COVID-19 Impact on the market

5. Global Drug Eluting Balloon Market, By Product Type, 2017 - 2030, (US$ Million)

Overview
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 - 2030
- Segment Trends
Coronary Drug Eluting Balloon
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Peripheral Drug Eluting Balloon
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

6. Global Drug Eluting Balloon Market, By End User, 2017 - 2030, (US$ Million)

Overview
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 - 2030
- Segment Trends
Hospitals
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
CATH Laboratories
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Ambulatory Surgery Centers
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

7. Global Drug Eluting Balloon Market, By Region, 2017 - 2030, (US$ Million)

Introduction
- Market Share Analysis, By Region, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, For Regions, 2017-2030
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
U.S.
Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
Brazil
Mexico
Argentina
Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
GCC
Israel
Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2017 - 2030, (US$ Million)
North Africa
Central Africa
South Africa